by rss feed | Nov 3, 2026 | News Feeds
The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval. Read Original...
by rss feed | Nov 3, 2026 | News Feeds
When you’re going through cancer treatment or recovering afterwards, rest might seem like the best medicine. Read Original...
by rss feed | Nov 3, 2026 | News Feeds
Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new...
by rss feed | Nov 3, 2026 | News Feeds
A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer....
by rss feed | Nov 3, 2026 | News Feeds
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including SARS-CoV-2, the virus that causes...
by rss feed | Nov 3, 2026 | News Feeds
This study reveals how a β-sheet cradle in PNGaseABif enhances glycopeptide processing, offering insights into microbial nutrient access in the infant gut. Read Original...
